Silicon Laboratories, Inc. $SLAB Shares Sold by Charles Schwab Investment Management Inc.

Key Points

• Charles Schwab Investment Management Inc. recently reduced its stake in Silicon Laboratories by 1.7%, selling 7,590 shares during the first quarter, while still owning 432,206 shares valued at approximately $48.7 million.
• Several institutional investors increased their holdings, with GAMMA Investing LLC growing its position by 99.6% in the first quarter, reflecting a trend of institutional interest in Silicon Laboratories' stock.
• Analysts have set a consensus price target of $151.13 for Silicon Laboratories, with a majority rating it as a "Moderate Buy" following recent upgrades from several brokerages.

Charles Schwab Investment Management Inc. trimmed its position in shares of Silicon Laboratories, Inc. (NASDAQ:SLAB - Free Report) by 1.7% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 432,206 shares of the semiconductor company's stock after selling 7,590 shares during the quarter. Charles Schwab Investment Management Inc. owned 1.33% of Silicon Laboratories worth $48,653,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Capital Research Global Investors boosted its holdings in Silicon Laboratories by 23.3% during the fourth quarter. Capital Research Global Investors now owns 2,131,920 shares of the semiconductor company's stock worth $264,827,000 after buying an additional 403,010 shares in the last quarter. Westfield Capital Management Co. LP purchased a new stake in Silicon Laboratories during the first quarter worth about $37,249,000. Mackenzie Financial Corp boosted its holdings in Silicon Laboratories by 11,746.2% during the first quarter. Mackenzie Financial Corp now owns 236,924 shares of the semiconductor company's stock worth $26,671,000 after buying an additional 234,924 shares in the last quarter. GAMMA Investing LLC boosted its holdings in Silicon Laboratories by 22,374.1% during the first quarter. GAMMA Investing LLC now owns 126,754 shares of the semiconductor company's stock worth $14,269,000 after buying an additional 126,190 shares in the last quarter. Finally, Raymond James Financial Inc. purchased a new stake in Silicon Laboratories during the fourth quarter worth about $14,252,000.

Insider Buying and Selling at Silicon Laboratories

In other news, SVP Brandon Tolany sold 2,270 shares of the business's stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $132.69, for a total value of $301,206.30. Following the completion of the transaction, the senior vice president owned 62,328 shares of the company's stock, valued at $8,270,302.32. The trade was a 3.51% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 1.60% of the stock is currently owned by corporate insiders.

Silicon Laboratories Price Performance

Shares of NASDAQ SLAB traded up $1.26 on Thursday, hitting $135.02. The company's stock had a trading volume of 208,977 shares, compared to its average volume of 395,840. Silicon Laboratories, Inc. has a 12-month low of $82.82 and a 12-month high of $160.00. The company has a market capitalization of $4.43 billion, a price-to-earnings ratio of -41.93 and a beta of 1.48. The stock has a 50 day moving average of $138.95 and a 200-day moving average of $127.88.

Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The semiconductor company reported $0.11 earnings per share for the quarter, beating analysts' consensus estimates of $0.09 by $0.02. The business had revenue of $192.85 million during the quarter, compared to analyst estimates of $192.57 million. Silicon Laboratories had a negative net margin of 14.88% and a negative return on equity of 7.21%. The company's revenue was up 32.6% on a year-over-year basis. During the same quarter in the previous year, the business posted ($0.56) earnings per share. Silicon Laboratories has set its Q3 2025 guidance at 0.200-0.400 EPS. Sell-side analysts expect that Silicon Laboratories, Inc. will post -0.97 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on SLAB shares. Benchmark reissued a "buy" rating and set a $160.00 price objective on shares of Silicon Laboratories in a report on Tuesday, May 27th. Barclays boosted their price objective on shares of Silicon Laboratories from $100.00 to $130.00 and gave the stock an "equal weight" rating in a report on Tuesday, August 5th. Stifel Nicolaus boosted their price objective on shares of Silicon Laboratories from $144.00 to $160.00 and gave the stock a "buy" rating in a report on Friday, July 18th. Wall Street Zen raised shares of Silicon Laboratories from a "sell" rating to a "hold" rating in a report on Wednesday, May 14th. Finally, KeyCorp upped their price target on shares of Silicon Laboratories from $160.00 to $180.00 and gave the company an "overweight" rating in a report on Tuesday, July 8th. Five analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $151.13.

Silicon Laboratories Profile

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.